ScreenerHero

EDVA Endovia Health Sciences, Inc.

AMEX · US · Healthcare · Biotechnology · endoviasciences.com
0.1470USD+4.93%Mkt Cap: 1.63M $P/E: —

Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, Unite…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
CSL
CSL Limited
$63.05BUSD
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7

Key Statistics

Company
Market Cap1.63M USD
Enterprise Value7.04M USD
Revenue (TTM)32.09K USD
Gross Profit16.90K USD
Net Income (TTM)-25.23M USD
Revenue/Share0.02 USD
Last Price0.1470 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.49
EV/Revenue219.47
P/S50.75
P/B-0.04
EPS (TTM)-23.44
EPS (Forward)—
52W Range
0.13440% of range13.40
52W High13.40 USD
52W Low0.1344 USD
Profitability
Gross Margin23.13%
Oper. Margin-45159.07%
EBITDA Margin0.00%
Profit Margin-34537.04%
ROE164.92%
ROA-2613.13%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.79M USD
CapEx (TTM)—
FCF Margin6942.67%
FCF Yield136.79%
Net Debt6.14M USD
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity-0.44
Current Ratio0.05
Quick Ratio0.02
Book Value/Sh-3.82 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJul 27, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.11.08M
Float6.40M
Insiders0.00%
Institutions2.51%
Short Interest
Short Ratio0.0d
Short % Float1.57%
Short % Out.1.57%
Shares Short173.90K
Short (prev mo.)228.35K
Technical
SMA 500.2873 (-48.8%)
SMA 2001.233 (-88.1%)
Beta-1.15
S&P 52W Chg17.50%
Avg Vol (30d)3.09M
Avg Vol (10d)1.33M
Technical Indicators
RSI (14)28.7
MACD-0.0487
MACD Signal-0.0541
MACD Hist.+0.0053
BB Upper0.2430 USD
BB Middle0.1780 USD
BB Lower0.1130 USD
BB Width73.03%
ATR (14)0.0293 USD
Vol Ratio (20d)0.07x